Acute experimental colitis decreases colonic circular smooth muscle contractility in rats.
Distal colitis decreases the contractility of the underlying circular smooth muscle. We examined how time after injury and lesion severity contribute to the decreased contractility and how colitis alters the calcium-handling properties of the affected muscle. Distal colitis was induced in rats by intrarectal administration of 4% acetic acid. Contractile responses to acetylcholine, increased extracellular potassium, and the G protein activator NaF were determined for circular muscle strips from sham control and colitic rats at days 1, 2, 3, 7, and 14 postenemas. Acetylcholine stimulation of tissues from day 3 colitic rats was performed in a zero calcium buffer, in the presence of nifedipine, and after depletion of intracellular stores of calcium. The colitis was graded macroscopically as mild, moderate, or severe. Regardless of agonist, maximal decrease in force developed 2 to 3 days posttreatment, followed by a gradual return to control by day 14. The inhibitory effect of colitis on contractility increased with increasing severity of inflammation. Limiting extracellular calcium influx had a greater inhibitory effect on tissues from colitic rats; intracellular calcium depletion had a greater inhibitory effect on tissues from control animals. The data suggest that both lesion severity and time after injury affect the contractile response of circular smooth muscle from the inflamed distal colon. Impaired utilization of intracellular calcium may contribute to the decreased contractility.
Myers
B S
BS
Department of Surgery, Temple University Hospital and School of Medicine, Philadelphia, Pennsylvania 19140, USA.
Martin
J S
JS
Dempsey
D T
DT
Parkman
H P
HP
Thomas
R M
RM
Ryan
J P
JP
D019342:Acetic Acid; D000109:Acetylcholine / Q000494:pharmacology; D000208:Acute Disease; D000818:Animals; D003092:Colitis / Q000139:chemically induced / Q000473:pathology / Q000503:physiopathology*; D003106:Colon / Q000473:pathology / Q000502:physiology / Q000503:physiopathology*; D019204:GTP-Binding Proteins / Q000378:metabolism; D005769:Gastrointestinal Motility / Q000187:drug effects / Q000502:physiology*; D066298:In Vitro Techniques; D007249:Inflammation; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects / Q000502:physiology*; D009130:Muscle, Smooth / Q000473:pathology / Q000502:physiology / Q000503:physiopathology*; D011188:Potassium / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D012969:Sodium Fluoride / Q000494:pharmacology; D013997:Time Factors
D012969:Sodium Fluoride; D019204:GTP-Binding Proteins; D000109:Acetylcholine; D019342:Acetic Acid; D011188:Potassium